etoposide

Generic: etoposide

Labeler: accord healthcare inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name etoposide
Generic Name etoposide
Labeler accord healthcare inc.
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

etoposide 20 mg/mL

Manufacturer
Accord Healthcare Inc.

Identifiers & Regulatory

Product NDC 16729-114
Product ID 16729-114_364ac37e-94f0-0dad-e063-6394a90aae33
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074513
Listing Expiration 2026-12-31
Marketing Start 2015-03-03

Pharmacologic Class

Established (EPC)
topoisomerase inhibitor [epc]
Mechanism of Action
topoisomerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16729114
Hyphenated Format 16729-114

Supplemental Identifiers

RxCUI
310248
UPC
0316729114318 0316729114110 0316729114080
UNII
6PLQ3CP4P3
NUI
N0000175609 N0000000176

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name etoposide (source: ndc)
Generic Name etoposide (source: ndc)
Application Number ANDA074513 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 1 VIAL, MULTI-DOSE in 1 BOX (16729-114-08) / 25 mL in 1 VIAL, MULTI-DOSE
  • 1 VIAL, MULTI-DOSE in 1 BOX (16729-114-11) / 50 mL in 1 VIAL, MULTI-DOSE
  • 1 VIAL, MULTI-DOSE in 1 BOX (16729-114-31) / 5 mL in 1 VIAL, MULTI-DOSE
source: ndc

Packages (3)

16729-114-08 1 VIAL, MULTI-DOSE in 1 BOX (16729-114-08) / 25 mL in 1 VIAL, MULTI-DOSE 16729-114-11 1 VIAL, MULTI-DOSE in 1 BOX (16729-114-11) / 50 mL in 1 VIAL, MULTI-DOSE 16729-114-31 1 VIAL, MULTI-DOSE in 1 BOX (16729-114-31) / 5 mL in 1 VIAL, MULTI-DOSE

Ingredients (1)

etoposide (20 mg/mL)

Linked Drug Pages (1)

Etoposide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "364ac37e-94f0-0dad-e063-6394a90aae33", "openfda": {"nui": ["N0000175609", "N0000000176"], "upc": ["0316729114318", "0316729114110", "0316729114080"], "unii": ["6PLQ3CP4P3"], "rxcui": ["310248"], "spl_set_id": ["4f850eb2-3542-43a0-90e8-bb37fa05cf15"], "pharm_class_epc": ["Topoisomerase Inhibitor [EPC]"], "pharm_class_moa": ["Topoisomerase Inhibitors [MoA]"], "manufacturer_name": ["Accord Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BOX (16729-114-08)  / 25 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "16729-114-08", "marketing_start_date": "20150303"}, {"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BOX (16729-114-11)  / 50 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "16729-114-11", "marketing_start_date": "20150303"}, {"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BOX (16729-114-31)  / 5 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "16729-114-31", "marketing_start_date": "20150322"}], "brand_name": "Etoposide", "product_id": "16729-114_364ac37e-94f0-0dad-e063-6394a90aae33", "dosage_form": "INJECTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "16729-114", "generic_name": "Etoposide", "labeler_name": "Accord Healthcare Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Etoposide", "active_ingredients": [{"name": "ETOPOSIDE", "strength": "20 mg/mL"}], "application_number": "ANDA074513", "marketing_category": "ANDA", "marketing_start_date": "20150303", "listing_expiration_date": "20261231"}